Marqibo and Ropivacaine Hydrochloride

• Generic Name: vincristine liposome
• Dosage Forms: n.a.
• Other Brand Names: Marqibo

Marqibo (vincristine liposome) is cancer medication that interferes with the growth of cancer cells and slows their spread in the body.

Marqibo is used to treat a type of blood cancer called Philadelphia chromosome negative acute lymphoblastic leukemia (ALL). It is usually given after at least two other cancer medications have been tried without success.

Marqibo may also be used for purposes not listed in this medication guide.

• Generic Name: ropivacaine
• Dosage Forms: n.a.
• Other Brand Names: Naropin, Naropin Polyamp, Naropin SDV, Naropin Novaplus

Local or regional anesthesia for surgery (including cesarean section) and management of acute pain (e.g., postoperative pain, labor pain).

Used as a component of multimodal analgesia (i.e., simultaneous use of a combination of analgesic drugs and techniques that target different mechanisms) in the management of postoperative pain.

Compared with bupivacaine, generally has a similar onset and duration of sensory block, but a lower intensity and shorter duration of motor block. Appears to have a lower potential for CNS and cardiovascular toxicity than bupivacaine.

Not recommended for obstetrical paracervical block, retrobulbar block for ophthalmic surgery, spinal anesthesia (subarachnoid block), or IV regional anesthesia (Bier block) because of lack of clinical experience and/or risk of toxicity.